Mercedes T. Mitjavila

Majadahonda, MD 28222, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Journal: The oncologist

Published: January 19, 2026

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Journal: The oncologist

Published: January 19, 2026

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 18, 2023

SEMNIM has a plan and is counting on you.

SEMNIM has a plan and is counting on you.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: December 12, 2022

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 06, 2022

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 22, 2021

SEMNIM, the power of all of us.

SEMNIM, the power of all of us.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: September 17, 2021

Recommendations for the nomenclature of radiolabeled compounds.

Recommendations for the nomenclature of radiolabeled compounds.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: October 30, 2019

Multimodal therapy in aggressive pituitary tumors.

Multimodal therapy in aggressive pituitary tumors.

Journal: Endocrinologia, diabetes y nutricion

Published: June 19, 2019

Noncirrhotic portal hypertension: An under-reported late adverse event of SIRT in metastatic colorectal cancer patients.

Noncirrhotic portal hypertension: An under-reported late adverse event of SIRT in metastatic colorectal cancer patients.

Journal: Journal of cancer research and therapeutics

Published: March 19, 2019

On professionalism in the management of thyroid tumors and multidisciplinary working groups (reply letter).

On professionalism in the management of thyroid tumors and multidisciplinary working groups (reply letter).

Journal: Endocrinologia, diabetes y nutricion

Published: March 19, 2019

Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature.

Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: December 12, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026